GL1X · GenesisL1 explorer

MolNFT v1 · #47569 · protein

Crystal structure of the VEGFR2 kinase domain in complex with a nicotinamide inhibitor

2P2I · Vascular endothelial growth factor receptor 2: “Crystal structure of the VEGFR2 kinase domain in complex with a nicotinamide inhibitor”. X-ray diffraction, 1 ligand (608), 3 pockets (best druggability 0.74). MolNFT v1 #47569 on…

PDB
2P2I
Type
protein
Length
552 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vascular endothelial growth factor receptor 2
EC
2.7.10.1
UniProt
P35968
Ligands
608
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein28943% helix, 16% strandP35968
BVascular endothelial growth factor receptor 2 (EC 2.7.10.1)protein26343% helix, 17% strandP35968

Ligands and binding sites

  • 608 · N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13090.740.8640608
22970.690.8335608
33410.590.7731empty

Interfaces

1 interface between chains.

  • A–B · 412 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 2P2I · Crystal structure of the VEGFR2 kinase domain in complex with a nicotinamide inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • P35968 · AlphaFold monomer V2.0 prediction for vascular endothelial growth factor receptor 2… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.